|
See related Xolair inj information |
|
|
|
Manufacturer |
Novartis |
|
Distributor |
Hong Kong: Zuellig/Macau: Four Star |
|
Contents |
Omalizumab |
|
Indications |
For adult & adolescent (≥12 yr) w/ moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen & whose symptoms are inadequately controlled w/ inhaled corticosteroids.
Click to view Xolair detailed prescribing infomation |
|
Dosage |
150-375 mg SC every 2 or 4 wk.
Click to view Xolair detailed prescribing infomation |
|
Overdosage |
View Xolair overdosage for action to be taken in the event of an overdose. |
|
Contraindications |
[Click for Xolair detailed prescribing infomation] |
|
Warnings |
For additional cautionary notes to warn of the potential risk of using the medicine... click to view Xolair detailed prescribing infomation |
|
Special Precautions |
Not for treatment of acute bronchospasm or status asthmaticus. Systemic or inhaled corticosteroids should not be abruptly discontinued upon initiation of therapy.
Click to view Xolair detailed prescribing infomation |
|
Adverse Drug Reactions |
Inj site reaction, viral infections, upper resp tract infection, sinusitis, headache & pharyngitis.
View ADR Monitoring Form |
|
Drug Interactions |
[Click for Xolair detailed prescribing infomation]
View more drug interactions with Xolair |
|
Pregnancy Category (US FDA) |
Category B: Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters). |
|
Storage |
View Xolair storage conditions for details to ensure optimal shelf-life. |
|
Description |
View Xolair description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Xolair mechanism of action for pharmacodynamics and pharmacokinetics details. |
